Simpson Thacher Establishes European Restructuring Practice With Leading Restructuring Lawyers
Simpson Thacher & Bartlett LLP announced today that Adam Gallagher and James Watson will join the Firm as Partners in the London office to establish a European Restructuring Practice.
“Simpson Thacher is a leader in providing innovative, strategic advice to clients facing financial distress, including as a result of recent market disruptions,” said Bill Dougherty, Chairman of Simpson Thacher’s Executive Committee. “Adam and James each bring an exceptional depth of experience in this area and are ideally positioned to expand our global restructuring capabilities. We are very pleased to welcome them to the Firm.”
Adam and James have extensive experience representing companies, as well as creditors and other key stakeholders across the capital structure, in connection with complex distressed situations. Their work includes advising on domestic and cross-border restructuring and formal insolvency matters, as well as counseling clients on a broad array of stressed and distressed investments and liability management transactions.
“Establishing a restructuring practice in Europe is a logical expansion of our existing platform and will further enhance our ability to serve clients across the corporate, private equity and financial sectors as a single source of best-in-class advice,” added Jason Glover, Managing Partner of the Firm’s London Office. “Adam and James are widely recognized in the market as trusted advisors to clients who are navigating complex restructuring matters. They are the perfect choice to establish and build our European restructuring capability and will be a wonderful complement to our deep bench of talent.”
“We are thrilled to have Adam and James join our restructuring team to establish and build our presence in the critical European market,” commented Sandy Qusba, Head of the Firm’s Restructuring and Bankruptcy Practice. “Simpson Thacher’s European Restructuring Practice will complement the Firm’s existing capabilities in the United States to provide comprehensive services in all aspects of restructurings, and stressed and distressed situations.”
Adam joins the Firm from Freshfields Bruckhaus Deringer LLP, where he became partner in 2007. James joins the Firm from Kirkland & Ellis LLP, where he became partner in 2017. Adam and James previously worked closely together at Freshfields for more than a decade.
ABOUT SIMPSON THACHER
Simpson Thacher & Bartlett LLP (www.simpsonthacher.com ) is one of the world’s leading international law firms. The Firm was established in 1884 and has more than 1,000 lawyers. Headquartered in New York with offices in Beijing, Hong Kong, Houston, London, Los Angeles, Palo Alto, São Paulo, Tokyo and Washington, D.C., the Firm provides coordinated legal advice and transactional capability to clients around the globe.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-C3.AI/BAKER-HUGHES26.2.2021 15:02:05 CET | Press release
C3 AI and Baker Hughes to Provide Enterprise AI Solutions to Accelerate PETRONAS Digital Transformation Program
AVANIA26.2.2021 14:02:10 CET | Press release
Avania in Position for Next Stage of Growth
IPSEN26.2.2021 12:39:07 CET | Press release
Ipsen Receives Positive CHMP Opinion Recommending Cabometyx® in Combination With Opdivo® as First-line Treatment for Patients Living With Advanced Renal Cell Carcinoma
CA-ANDERSEN-GLOBAL26.2.2021 11:53:13 CET | Pressemeddelelse
Andersen Global styrker sin caribiske platform med Baptiste & Co. Law Firm
HIRO-CAPITAL26.2.2021 09:57:10 CET | Press release
Hiro Capital Leads $15 Million of Games VC Investment Into Snowprint Studios, Double Loop Games and Happy Volcano Games
INSPUR-INFORMATION26.2.2021 09:09:06 CET | Press release
Inspur Information Releases 2020 Global Computing Index Report
DE-INCYTE26.2.2021 09:02:05 CET | Press release
Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom